General | Carbohydrate O/F | Substrate utilisation | Enzymes | Metabolites | Antibiotics

Overview


  • Prevotella salivae is a Gram-negative, non-spore-forming, strictly anaerobic, non-motile, rod-shaped bacterium. It has been detected in at least 6 gut microbiome compilation studies or metastudies. The DNA G+C content is 41.3%. Prevotella salivae is probably a rare gut coloniser. (Sakamoto2004)



  • This organism has been recovered from human faeces and saliva of patient with chronic periodontitis. The risk classification (www.baua.de) for this organism is 1, i.e., low risk of infection and spread (notes: opportunistic in immunocompromised patients). Can cause opportunistic infections, particularly in immunocompromised people. A possible gut commensal.

  • QUIRKS
  • Homoacetogen.

  • GENERAL CHARACTERISTICS (Sakamoto2004);
    Character Response
  • Substrates hydrolysed or digested:
  • aesculin;
  • 💧
  • Bile tolerance:
  • Doesn't tolerate 20% bile
  • pH
  • Acidity tolerance:
  • Grows optimally at pH 7-7.3.
  • 🌡
  • Temperature tolerance:
  • Grows optimally at 37℃.
  • H+
  • Acid from carbohydrates usually produced:
  • L-arabinose; glucose; mannose; xylose; cellubiose; lactose; maltose; raffinose; sucrose; salicin;
  • Active enzymes:
  • alkaline phosphatase; arabinosidase; acid phosphatase; N-Ac β-glucosaminidase; α-galactosidase; β-galactosidase; α-glucosidase; β-glucosidase; naphthol-ASBI-P;

  • SPECIAL FEATURES (Sakamoto2004);
    Character Response
  • Metabolites produced:
  • acetate (major); succinate (major); isovalerate (minor);
  • Metabolites not produced:
  • indole;
  • Pigments:
  • not produced

  • Details


    GENERAL
    Lineage Physiology General Growth Tolerances Hydrol./digest./degr.
    Phylum:  Bacteroidetes Class:  Bacteroidia Order:  Bacteroidales Family:  Prevotellaceae Genus:  Prevotella Gram stain:  neg O2 Relation.:  strictly anaerobic Spore:  No spore Motility:  Sessile Morphology:  Rod Pigment:  neg
    Health:  Unknown
    Source:  human faeces and saliva of patient with chronic periodontitis
    DNA G+C(%):  41.3
    Opt. T:  37℃
    Opt. pH:  7-7.3
    Bile reaction(%):  20(neg)
    Aesculin:  + Urea:  neg Gelatin:  neg

    CARBOHYDRATE ACID FORMATION
    Monosaccharide O/F Oligosaccharide O/F Polysaccharide O/F Polyol O/F Other O/F
    L-Arabinose:  + Glucose:  + Mannose:  + Rhamnose:  neg Xylose:  + Cellubiose:  + Lactose:  + Maltose:  + Melezitose:  neg Sucrose:  + Trehalose:  neg Glycerol:  neg Mannitol:  neg Sorbitol:  neg Salicin:  +

    ENZYME ACTIVITY
    Enzymes: General Enzymes: Carbohydrate Enzymes: Protein Enzymes: Arylamidases Enzymes: Esters/fats
    Catalase:  neg Urease:  neg G6PDH6PGDH:  neg α-Arab:  + Ac-β-glcamnd:  + α-Fucosidase:  w α-Galactosidase:  + β-Galactosidase:  + α-Glucosidase:  + β-Glucosidase:  + β-Glucuronidase:  neg α-Mannosidase:  neg Chymotrypsin:  neg GlyAP:  neg Trypsin:  neg ArgAA:  neg CystineAA:  neg LeuAA:  neg ProAA:  neg PheAA:  neg PyrogluAA:  neg TyrAA:  neg ValAA:  neg AlkalineP:  + AcidP:  + Esterase(C4):  neg EstLip(C8):  neg Lipase:  neg Lipase(C14):  neg

    METABOLITES - PRODUCTION & USE
    Fuel Usable Metabolites Metabolites Released Special Products Compounds Produced

    Acetate:  Major(+) Succinate:  Major(+) Isovalerate:  minor(+) Indole:  neg Pigment:  neg

    References


    SPECIFIC REFERENCES FOR PREVOTELLA SALIVAE
  • Sakamoto2004 - Prevotella shahii sp. nov. and Prevotella salivae sp. nov., isolated from the human oral cavity.
  • ...............................
  • GUT MICROBIOME COMPILATIONS AND METASTUDIES FOR PREVOTELLA SALIVAE
  • Byrd2020 - Stability and dynamics of the human gut microbiome and its association with systemic immune traits.
  • Forster2019 - A human gut bacterial genome and culture collection for improved metagenomic analyses.
  • Lagier2016 - Culture of previously uncultured members of the human gut microbiota by culturomics.
  • Tyakht2013 - Human gut microbiota community structures in urban and rural populations in Russia.
  • Zeller2014 - Potential of fecal microbiota for early-stage detection of colorectal cancer
  • ...............................